Cleveland Biolabs (CBLI) Reports Q1 Loss of $1.14

Cleveland Biolabs (NASDAQ: CBLI) reported Q1 EPS of ($1.14), versus ($0.63) reported last year. Revenue for the quarter came in at $607.33 thousand versus the consensus estimate of $1.33 million.

For earnings history and earnings-related data on Cleveland Biolabs (CBLI) click here.

You May Also Be Interested In

• Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
• Bernstein SocGen on Meta Platforms Inc. (META): 'Risk-reward remains attractive'
• Arena Group to rename as Paradium.AI, ticker changing to PAAI